Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Clofazimine has no influence on the blood concentrations of tezacaftor-ivacaftor in a patient with cystic fibrosis.

Clofazimine has no influence on the blood concentrations of tezacaftor-ivacaftor in a patient with cystic fibrosis.

Resource Type

CF Research News

Authors

S E M Vonk, S W J Terheggen-Lagro, L M Mouissie, R A A Mathôt, E M Kemper, Amsterdam Mucociliary Clearance Disease (AMCD) research group

References

J Cyst Fibros. 2021 Oct 29;S1569-1993(21)02105-6. doi: 10.1016/j.jcf.2021.10.003.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Lung Disease and Infection [4]

Keywords

Clofazimine [5]
Drug-drug interaction [6]
Tezacaftor-ivacaftor [7]

Date

Friday, October 29, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/clofazimine-has-no-influence-blood-concentrations-tezacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00317R1_FINAL_Vonk_061121.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34756823/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/lung-disease-and-infection [5] https://www.ecfs.eu/research-article-keywords/clofazimine [6] https://www.ecfs.eu/research-article-keywords/drug-drug-interaction [7] https://www.ecfs.eu/research-article-keywords/tezacaftor-ivacaftor [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines